Latest News

Etsy agreed to sell Depop to eBay for $1.2b, stepping back from its house of brands approach to focus on its core marketplace. The Supreme Court struck down tariffs that had affected cross border trade, a change that could support Etsy's international operations. These developments arrive as Etsy (NYSE:ETSY) trades around $52.37 and works through mixed share performance in recent years. Etsy, trading at about $52.37, has seen a 14.5% gain over the past week alongside a 13.0% decline over...

AI risk report and $200b shelf registration put Morgan Stanley in focus A research report on economic risks from AI agents has put Morgan Stanley (MS) under fresh scrutiny, as investors weigh pressure on bank profits against the company’s new $200b mixed shelf registration. See our latest analysis for Morgan Stanley. At a share price of $166.8, Morgan Stanley has seen a 1-day share price return decline of 4.91% and a 30-day share price return decline of 6.82%. Its 1-year total shareholder...

The Coca-Cola Company recently approved its 64th consecutive annual dividend increase to US$0.53 per share and named long-time finance executive Todd Beiger as vice president and head of investor relations, while preparing for Henrique Braun to assume the CEO role on March 31, 2026. Alongside these leadership and capital-return moves, Coca-Cola reported higher 2025 sales of US$47,941 million and net income of US$13,107 million, underlining how operational execution and shareholder...

Why Essential Utilities Is On Watch Now Essential Utilities (WTRG) has caught investor attention after a period of mixed share performance, with a small gain over the past month alongside a slight decline over the past 3 months. That backdrop has some investors revisiting the company’s fundamentals, including its regulated water and natural gas businesses and recent financial figures, to decide whether the current pricing fairly reflects its long term prospects. See our latest analysis for...

Amicus Therapeutics (FOLD) has drawn investor attention after a strong past 3 months, with a total return of about 45% and a 1-year total return above 50%, prompting closer scrutiny of its fundamentals. See our latest analysis for Amicus Therapeutics. The recent move in Amicus Therapeutics' share price to $14.36 sits on top of a strong 90 day share price return of about 45%, while the 1 year total shareholder return of roughly 54% points to momentum that has been building rather than...

Superior Plus (TSX:SPB) has revised its multi-year outlook, extending completion of its "Superior Delivers" transformation program to 2028. The company now expects a lower EBITDA growth rate for 2024 to 2027, reflecting operational and market challenges. These changes adjust expectations around execution timing and future value creation for shareholders. Superior Plus operates in energy distribution and related services, a space that can be sensitive to weather patterns, commodity prices,...

MercadoLibre (MELI) is back in focus as investors watch for Q4 2025 earnings after today’s close, with attention on revenue growth, profitability signals, and fresh commentary following a recent JPMorgan upgrade. See our latest analysis for MercadoLibre. The current US$1,864.46 share price comes after a 1 month share price return of 12.77% and a year to date share price return of a 5.53% decline, while the 1 year total shareholder return of a 16.14% decline contrasts with a 3 year total...

ImmunityBio, Inc. recently reported fourth-quarter 2025 results showing revenue of US$38.29 million versus US$7.55 million a year earlier, alongside a net loss of US$61.94 million, while also securing European conditional marketing authorization and new regional partnerships to commercialize its immunotherapy ANKTIVA across Europe and the Middle East. These moves give ImmunityBio its first broad international commercial footprint for ANKTIVA in bladder cancer and lung cancer, supported by...

Interest in MongoDB (MDB) has picked up after fresh analyst commentary framed it as a key database player for GenAI and Agentic AI applications ahead of its upcoming fourth quarter fiscal 2026 earnings report. See our latest analysis for MongoDB. That upbeat GenAI narrative is colliding with a sharp reset in expectations, with the share price at US$305.37 after a 23.6% year to date share price decline, but a 14.3% 1 year total shareholder return that points to longer term confidence holding...

Why Brambles shares are in focus today Brambles (ASX:BXB) has drawn fresh attention after issuing lower sales growth guidance for fiscal 2026, alongside half year results that included higher net income and an ordinary dividend of US$0.23 per share. See our latest analysis for Brambles. The news around reduced sales growth guidance and a higher ordinary dividend comes after a stretch of positive momentum, with a 30 day share price return of 6.75% and a 1 year total shareholder return of...

American Electric Power Company, Inc. reported past full-year 2025 results showing higher sales of US$21.35 billion and revenue of US$21.88 billion, stronger net income of US$3.58 billion, higher earnings per share, reaffirmed its 2026 operating earnings outlook, and announced that director Henry P. Linginfelter will not stand for re-election in 2026. Alongside these results, AEP increased its quarterly dividend to US$0.95 per share and highlighted a substantial pipeline of infrastructure...

Earlier in February 2026, DaVita Inc. completed two major share repurchase tranches under its 2020 and 2024 buyback programs, retiring millions of shares for a combined outlay of more than US$5.63 billion. This large-scale reduction in share count, alongside CEO Javier Rodriguez’s upcoming appearance at the ViVE 2026 conference in Los Angeles, highlights how DaVita is pairing capital returns with a focus on its long-term care and technology agenda. We’ll now examine how the completion of...

Earlier in 2026, Hub Group disclosed that its quarterly financial reports from March 31, 2025 onward could no longer be relied upon after identifying understated purchased transportation costs and accounts payable, prompting plans to restate results and review internal controls for 2023–2024. The accounting issue, estimated at about US$77,000,000 and now the focus of multiple law firm investigations, has raised fresh questions about the reliability of Hub Group’s recent financial reporting...

InnoCare Pharma (SEHK:9969) has drawn fresh investor attention after dosing the first patient in a Phase II/III trial of TYK2 inhibitor soficitinib for chronic spontaneous urticaria, alongside progress across multiple late stage dermatology programs. See our latest analysis for InnoCare Pharma. The new dermatology trial news comes after a mixed price patch, with a 7.71% 1 month share price return and a 1 year total shareholder return of 63.92%, even though the 90 day share price return shows...

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...

Why ManpowerGroup is on investors’ radar ManpowerGroup (MAN) has drawn attention after a prolonged share price slump, with the stock showing negative total returns over the past year, past 3 months, and month. This has prompted investors to reassess its current valuation. See our latest analysis for ManpowerGroup. The share price has reset sharply, with a 1 day share price return of an 8.83% decline and a 30 day share price return of a 14.61% decline, while the 1 year total shareholder return...

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...

If you are wondering whether Sempra is fairly priced or if there could be value left on the table, starting with the recent share performance and valuation checks can help frame that question. Sempra shares last closed at US$93.60, with returns of 8.9% over 30 days, 4.3% year to date, 10.9% over 1 year, 33.1% over 3 years, and 86.2% over 5 years. Recent coverage of Sempra has focused on its role as a US utilities player, investor interest in income and infrastructure names, and how these...

In February 2026, IPH Limited announced a buyback of up to 12,234,748 shares, lifting its interim dividend to A$0.19 per share and reporting higher half-year revenue of A$365.1 million and net income of A$41.2 million for the six months to December 31, 2025. These moves, alongside reduced net debt and growth in earnings per share, underline IPH’s focus on capital management and reinforcing shareholder returns despite ANZ regional headwinds. We’ll now examine how IPH’s higher interim dividend...

RH (RH) is back in focus after reporting 9% revenue growth in 2025 during what it called the worst housing market in almost 50 years, while rolling out new sourcebooks and reshaping its store footprint. See our latest analysis for RH. RH’s latest sourcebook launches and store footprint changes come against a weak share price backdrop, with a 17.08% 1 month share price decline and a 45.30% 1 year total shareholder return loss. The 90 day share price return of 18.65%, however, hints at...

ReNew Energy Global (RNW) is back on investors’ radar after its latest earnings release, which highlighted strong year over year revenue growth, higher electricity sales from wind and solar, and a sharp improvement in adjusted EBITDA. See our latest analysis for ReNew Energy Global. Despite the strong Q3 earnings update, ReNew Energy Global’s recent trading has been mixed. The 1-day share price return is 1.67% and the 7-day share price return is 2.62%, compared with a 90-day share price...

If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies. The stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks. Recent news coverage around Harmony Biosciences has focused on the...

Lundin Mining reported full-year 2025 results, lifting sales to US$4,053.2 million from US$3,270.1 million and moving from a US$203.5 million net loss to US$1,283 million in net income, while also declaring a regular quarterly dividend of C$0.0275 per share payable in April 2026. Alongside the earnings rebound, the company released extensive updates to its Mineral Resources and Reserves, underscoring the scale of copper, gold, and silver contained in assets such as Vicuña, Filo del Sol,...